Smart healthcare support for advanced stomach cancer patients on immunotherapy
Part of Cancer, Digestive system clinical trials.
This study tests a program that uses smart technology to provide personalized symptom management education and home-based exercises for people with advanced stomach cancer receiving immunotherapy. The goal is to help reduce frailty and treatment side effects, and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced stomach cancer (stage III or IV, or cancer that cannot be removed with surgery).
- You are about to start your first round of immunotherapy (a treatment that helps your immune system fight cancer).
- You are willing to follow the study plan and provide written consent.
- You have not had another type of cancer in the last 5 years (except for certain skin cancers or early-stage cancers).
- You do not have serious health conditions like recent heart attack, blood clot in the lungs, broken bone in the arm or leg in the last 3 months, or cancer that has spread to the bones.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze CT scans, blood, and tumor tissue to predict how well your cancer will respond to chemotherapy and immunotherapy before surgery. It aims to personalize treatment for locally advanced stomach or gastroesophageal junction cancer.
This study tests whether giving immunotherapy before surgery can help shrink advanced stomach cancer and improve outcomes. Immunotherapy uses your body's own immune system to fight cancer cells.
This trial tests an immunotherapy that uses your own immune cells to fight advanced digestive-system cancers. It aims to see if this treatment is safe and if it can help shrink tumors or slow their growth.
This early-phase trial tests a new type of immune cell therapy (TCRx T cells) for advanced stomach cancer that has not responded to standard chemotherapy. The goal is to see if these specially engineered cells can help your body fight the cancer.
This trial tests a home-based program before surgery that uses 5G and artificial intelligence to guide your exercises and health monitoring. The goal is to improve your strength and recovery before and after stomach cancer surgery.
This study tests a treatment approach for stomach cancer that hasn't spread to other organs. It's for people who have not had any prior cancer treatments and are in relatively good health.
Hear when a new Immunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.